Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats

Andrew Evan, Sharon B. Bledsoe, Susan B. Smith, David A. Bushinsky

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background. The inbred genetic hypercalciuric stone-forming (GHS) rats develop calcium phosphate (apatite) stones when fed a normal 1.2% calcium diet. The addition of 1% hydroxyproline to this diet does not alter the type of stone formed, while rats fed this diet with 3% hydroxyproline form mixed apatite and calcium oxalate stones and those with 5% hydroxyproline added form only calcium oxalate stones. The present study was designed to determine the localization of stone formation and if this solid phase resulted in pathologic changes to the kidneys. Methods. GHS rats were fed 15 g of the standard diet or the diet supplemented with 1%, 3%, or 5% hydroxyproline for 18 weeks. A separate group of Sprague-Dawley rats (the parental strain of the GHS rats), fed the standard diet for a similar duration, served as an additional control. At 18 weeks, all kidneys were perfusion-fixed for structural analysis, detection of crystal deposits using the Yasue silver substitution method, and osteopontin immunostaining. Results. There were no crystal deposits found in the kidneys of Sprague-Dawley rats. Crystal deposits were found in the kidneys of all GHS rats and this Yasue-stained material was detected only in the urinary space. No crystal deposits were noted within the cortical or medullary segments of the nephron and there was no evidence for tubular damage in any group. The only pathologic changes occurred in 3% and 5% hydroxyproline groups with the 5 % group showing the most severe changes. In these rats, which form only calcium oxalate stones, focal sites along the urothelial lining of the papilla and fornix of the urinary space demonstrated a proliferative response characterized by increased density of urothelial cells that surrounded the crystal deposits. At the fornix, some crystals were lodged within the interstitium, deep to the proliferative urothelium. There was increased osteopontin immunostaining in the proliferating urothelium. Conclusion. Thus in the GHS rat, the initial stone formation occurred solely in the urinary space. Tubular damage was not observed with either apatite or calcium oxalate stones. The apatite stones do not appear to cause any pathological change while those rats forming calcium oxalate stones have a proliferative response of the urothelium, with increased osteopontin immunostaining, around the crystal deposits in the fornix.

Original languageEnglish (US)
Pages (from-to)154-161
Number of pages8
JournalKidney International
Volume65
Issue number1
DOIs
StatePublished - Jan 2004
Externally publishedYes

Fingerprint

Calcium Oxalate
Osteopontin
Apatites
Diet
Urothelium
Hydroxyproline
Kidney
Sprague Dawley Rats
Nephrons
Silver
Perfusion
Cell Count
Calcium

ASJC Scopus subject areas

  • Nephrology

Cite this

Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. / Evan, Andrew; Bledsoe, Sharon B.; Smith, Susan B.; Bushinsky, David A.

In: Kidney International, Vol. 65, No. 1, 01.2004, p. 154-161.

Research output: Contribution to journalArticle

Evan, Andrew ; Bledsoe, Sharon B. ; Smith, Susan B. ; Bushinsky, David A. / Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. In: Kidney International. 2004 ; Vol. 65, No. 1. pp. 154-161.
@article{e4432cafc94c45e896d11b9364d8f860,
title = "Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats",
abstract = "Background. The inbred genetic hypercalciuric stone-forming (GHS) rats develop calcium phosphate (apatite) stones when fed a normal 1.2{\%} calcium diet. The addition of 1{\%} hydroxyproline to this diet does not alter the type of stone formed, while rats fed this diet with 3{\%} hydroxyproline form mixed apatite and calcium oxalate stones and those with 5{\%} hydroxyproline added form only calcium oxalate stones. The present study was designed to determine the localization of stone formation and if this solid phase resulted in pathologic changes to the kidneys. Methods. GHS rats were fed 15 g of the standard diet or the diet supplemented with 1{\%}, 3{\%}, or 5{\%} hydroxyproline for 18 weeks. A separate group of Sprague-Dawley rats (the parental strain of the GHS rats), fed the standard diet for a similar duration, served as an additional control. At 18 weeks, all kidneys were perfusion-fixed for structural analysis, detection of crystal deposits using the Yasue silver substitution method, and osteopontin immunostaining. Results. There were no crystal deposits found in the kidneys of Sprague-Dawley rats. Crystal deposits were found in the kidneys of all GHS rats and this Yasue-stained material was detected only in the urinary space. No crystal deposits were noted within the cortical or medullary segments of the nephron and there was no evidence for tubular damage in any group. The only pathologic changes occurred in 3{\%} and 5{\%} hydroxyproline groups with the 5 {\%} group showing the most severe changes. In these rats, which form only calcium oxalate stones, focal sites along the urothelial lining of the papilla and fornix of the urinary space demonstrated a proliferative response characterized by increased density of urothelial cells that surrounded the crystal deposits. At the fornix, some crystals were lodged within the interstitium, deep to the proliferative urothelium. There was increased osteopontin immunostaining in the proliferating urothelium. Conclusion. Thus in the GHS rat, the initial stone formation occurred solely in the urinary space. Tubular damage was not observed with either apatite or calcium oxalate stones. The apatite stones do not appear to cause any pathological change while those rats forming calcium oxalate stones have a proliferative response of the urothelium, with increased osteopontin immunostaining, around the crystal deposits in the fornix.",
author = "Andrew Evan and Bledsoe, {Sharon B.} and Smith, {Susan B.} and Bushinsky, {David A.}",
year = "2004",
month = "1",
doi = "10.1111/j.1523-1755.2004.00396.x",
language = "English (US)",
volume = "65",
pages = "154--161",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats

AU - Evan, Andrew

AU - Bledsoe, Sharon B.

AU - Smith, Susan B.

AU - Bushinsky, David A.

PY - 2004/1

Y1 - 2004/1

N2 - Background. The inbred genetic hypercalciuric stone-forming (GHS) rats develop calcium phosphate (apatite) stones when fed a normal 1.2% calcium diet. The addition of 1% hydroxyproline to this diet does not alter the type of stone formed, while rats fed this diet with 3% hydroxyproline form mixed apatite and calcium oxalate stones and those with 5% hydroxyproline added form only calcium oxalate stones. The present study was designed to determine the localization of stone formation and if this solid phase resulted in pathologic changes to the kidneys. Methods. GHS rats were fed 15 g of the standard diet or the diet supplemented with 1%, 3%, or 5% hydroxyproline for 18 weeks. A separate group of Sprague-Dawley rats (the parental strain of the GHS rats), fed the standard diet for a similar duration, served as an additional control. At 18 weeks, all kidneys were perfusion-fixed for structural analysis, detection of crystal deposits using the Yasue silver substitution method, and osteopontin immunostaining. Results. There were no crystal deposits found in the kidneys of Sprague-Dawley rats. Crystal deposits were found in the kidneys of all GHS rats and this Yasue-stained material was detected only in the urinary space. No crystal deposits were noted within the cortical or medullary segments of the nephron and there was no evidence for tubular damage in any group. The only pathologic changes occurred in 3% and 5% hydroxyproline groups with the 5 % group showing the most severe changes. In these rats, which form only calcium oxalate stones, focal sites along the urothelial lining of the papilla and fornix of the urinary space demonstrated a proliferative response characterized by increased density of urothelial cells that surrounded the crystal deposits. At the fornix, some crystals were lodged within the interstitium, deep to the proliferative urothelium. There was increased osteopontin immunostaining in the proliferating urothelium. Conclusion. Thus in the GHS rat, the initial stone formation occurred solely in the urinary space. Tubular damage was not observed with either apatite or calcium oxalate stones. The apatite stones do not appear to cause any pathological change while those rats forming calcium oxalate stones have a proliferative response of the urothelium, with increased osteopontin immunostaining, around the crystal deposits in the fornix.

AB - Background. The inbred genetic hypercalciuric stone-forming (GHS) rats develop calcium phosphate (apatite) stones when fed a normal 1.2% calcium diet. The addition of 1% hydroxyproline to this diet does not alter the type of stone formed, while rats fed this diet with 3% hydroxyproline form mixed apatite and calcium oxalate stones and those with 5% hydroxyproline added form only calcium oxalate stones. The present study was designed to determine the localization of stone formation and if this solid phase resulted in pathologic changes to the kidneys. Methods. GHS rats were fed 15 g of the standard diet or the diet supplemented with 1%, 3%, or 5% hydroxyproline for 18 weeks. A separate group of Sprague-Dawley rats (the parental strain of the GHS rats), fed the standard diet for a similar duration, served as an additional control. At 18 weeks, all kidneys were perfusion-fixed for structural analysis, detection of crystal deposits using the Yasue silver substitution method, and osteopontin immunostaining. Results. There were no crystal deposits found in the kidneys of Sprague-Dawley rats. Crystal deposits were found in the kidneys of all GHS rats and this Yasue-stained material was detected only in the urinary space. No crystal deposits were noted within the cortical or medullary segments of the nephron and there was no evidence for tubular damage in any group. The only pathologic changes occurred in 3% and 5% hydroxyproline groups with the 5 % group showing the most severe changes. In these rats, which form only calcium oxalate stones, focal sites along the urothelial lining of the papilla and fornix of the urinary space demonstrated a proliferative response characterized by increased density of urothelial cells that surrounded the crystal deposits. At the fornix, some crystals were lodged within the interstitium, deep to the proliferative urothelium. There was increased osteopontin immunostaining in the proliferating urothelium. Conclusion. Thus in the GHS rat, the initial stone formation occurred solely in the urinary space. Tubular damage was not observed with either apatite or calcium oxalate stones. The apatite stones do not appear to cause any pathological change while those rats forming calcium oxalate stones have a proliferative response of the urothelium, with increased osteopontin immunostaining, around the crystal deposits in the fornix.

UR - http://www.scopus.com/inward/record.url?scp=0347362501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347362501&partnerID=8YFLogxK

U2 - 10.1111/j.1523-1755.2004.00396.x

DO - 10.1111/j.1523-1755.2004.00396.x

M3 - Article

VL - 65

SP - 154

EP - 161

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 1

ER -